Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Locilex
2. Msi 78
3. Msi-78
4. Pexiganan
5. Pexiganan Acetate
1. Pexiganan Acetate
2. 172820-23-4
3. Mangainin
4. Chembl4164909
5. Glycyl-isoleucyl-glycyl-lysyl-phenylalanyl-leucyl-lysyl-lysyl-alanyl-lysyl-lysyl-phenylalanyl-glycyl-lysy--alanyl-phenylalanyl-valyl-lysyl-isoleucyl-leucyl-lysyl-lysinamide Acetate
| Molecular Weight | 2477.2 g/mol |
|---|---|
| Molecular Formula | C122H210N32O22 |
| XLogP3 | 1 |
| Hydrogen Bond Donor Count | 32 |
| Hydrogen Bond Acceptor Count | 32 |
| Rotatable Bond Count | 94 |
| Exact Mass | 2476.6331013 g/mol |
| Monoisotopic Mass | 2475.6297465 g/mol |
| Topological Polar Surface Area | 914 Ų |
| Heavy Atom Count | 176 |
| Formal Charge | 0 |
| Complexity | 4940 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 20 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
ABOUT THIS PAGE
A Cytolex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cytolex, including repackagers and relabelers. The FDA regulates Cytolex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cytolex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cytolex supplier is an individual or a company that provides Cytolex active pharmaceutical ingredient (API) or Cytolex finished formulations upon request. The Cytolex suppliers may include Cytolex API manufacturers, exporters, distributors and traders.
click here to find a list of Cytolex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cytolex DMF (Drug Master File) is a document detailing the whole manufacturing process of Cytolex active pharmaceutical ingredient (API) in detail. Different forms of Cytolex DMFs exist exist since differing nations have different regulations, such as Cytolex USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cytolex DMF submitted to regulatory agencies in the US is known as a USDMF. Cytolex USDMF includes data on Cytolex's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cytolex USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cytolex suppliers with USDMF on PharmaCompass.
Cytolex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cytolex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cytolex GMP manufacturer or Cytolex GMP API supplier for your needs.
A Cytolex CoA (Certificate of Analysis) is a formal document that attests to Cytolex's compliance with Cytolex specifications and serves as a tool for batch-level quality control.
Cytolex CoA mostly includes findings from lab analyses of a specific batch. For each Cytolex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cytolex may be tested according to a variety of international standards, such as European Pharmacopoeia (Cytolex EP), Cytolex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cytolex USP).
LOOKING FOR A SUPPLIER?
